OverviewChartNewsTraderScreen

ZimVie Inc/  US98888T1079  /

IEX
21/05/2024  16:53:28 Chg. +0.14 Volume Bid- Ask16:56:53 High Low
17.16USD +0.82% 792
Turnover: 13,610.44		 -Bid Size: - 17.31Ask Size: 108 17.27 16.73
GlobeNewswire 16/05 ZimVie to Participate in Upcoming Investor Conferences
GlobeNewswire 08/05 ZimVie Reports First Quarter 2024 Financial Results
GlobeNewswire 24/04 ZimVie to Report First Quarter Financial Results on May 8, 2024
GlobeNewswire 01/04 ZimVie Announces Closing of Sale of Spine Business
GlobeNewswire 27/03 ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire 28/02 ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 21/02 ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
GlobeNewswire 07/02 ZimVie Announces Launch of Next-Generation TSX® Implant in Japan
GlobeNewswire 18/12/2023 ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million
GlobeNewswire 12/12/2023 ZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma...
GlobeNewswire 01/11/2023 ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
GlobeNewswire 31/10/2023 ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc
GlobeNewswire 24/10/2023 ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT
GlobeNewswire 17/10/2023 ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions
GlobeNewswire 11/10/2023 ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023
GlobeNewswire 10/10/2023 ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane
GlobeNewswire 26/09/2023 ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
GlobeNewswire 17/08/2023 ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
GlobeNewswire 01/03/2022 ZimVie Completes Separation from Zimmer Biomet; Announces Board of Directors